ALFUZOSINA AUROBINDO 10mg prolonged tablets medication leaflet

G04CA01 alfuzosin • Genito urinary system and sex hormones | Drugs used in benign prostatic hypertrophy | Alpha-adrenoreceptor antagonists

Alfuzosin is a medication used to treat symptoms associated with benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate that can cause difficulty urinating. Alfuzosin belongs to the class of alpha-blockers and works by relaxing the smooth muscles in the prostate and bladder neck, making it easier to urinate.

It is taken orally, usually once daily after a meal, to reduce the risk of side effects. Beneficial effects may be noticed within a few days of starting treatment.

Common side effects include dizziness, fatigue, headache, or orthostatic hypotension (a drop in blood pressure when standing up). Patients are advised to avoid sudden movements to prevent dizziness. Alfuzosin is contraindicated in patients with severe liver impairment or those taking other medications that may interact with it. It should be used as directed by a doctor.

General data about ALFUZOSINA AUROBINDO 10mg

Substance: alfuzosin

Date of last drug list: 01-09-2021

Commercial code: W67849005

Concentration: 10mg

Pharmaceutical form: prolonged tablets

Quantity: 1000

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: APL SWIFT SERVICES (MALTA) LIMITED - MALTA

Holder: AUROBINDO PHARMA ROMANIA S.R.L. - ROMANIA

Number: 9539/2016/05

Shelf life: 3 years

Pharmaceutical forms available for alfuzosin

Concentrations available for alfuzosin

10mg, 2.5mg, 5mg

Other substances similar to alfuzosin